Multiple sclerosis patients who received N-acetylcysteine treatments had improvements in metabolism in brain areas associated with cognition and attention.
A new study reports reveratrol could be a therapeutic candidate for the management and treatment of Alzheimer's disease.
Antioxidant shows promise as treatment for certain features of autism, Stanford study finds A specific antioxidant supplement may be an...
Study supports urate protection against Parkinson’s disease, hints at novel mechanism In vitro study indicates urate protection extends beyond antioxidant...
